Drug Policy Conference Preliminary Agenda

Preliminary Agenda for Monday, March 15, 2010

Time Room Activity    
7:15-8:00 A Registration
7:30-8:15 A Light breakfast
8:15-8:30 A Welcome
      Michael Rich Executive Vice President, RAND Corporation
      Rosalie Pacula Program Committee Chair, RAND Corporation
      Peter Reuter ISSDP President, University of Maryland
8:30-9:15 A Plenary #1: Dr. Antonio Maria Costa, Executive Director, United Nations Office of Drugs and Crime
9:15-9:35   Break
9:40-10:55   Breakout #1:
  A National policy panel I
    Chair Peter Reuter  
      David McDonald Using theories of policy processes in evaluating national drug strategies: The case of the 2009 evaluation of Australia's National Drug Strategy
      Franz Trautmann Evaluation of the National Drug Action Plan (2005-2009) of Luxembourg
      Margriet van Laar & Marianne van Ooyen-Houben Dutch drug policy evaluated
    Discussant Ethan Nadelmann  
  B Harm reduction and drug-related HIV
    Chair Dr. Zunyou Wu  
      Mohammad Shahbazi The first syringe exchange program in Iran prisons
      Martin Iguchi Drugs and HIV in the U.S. and Russia
      Frank Wong HIV and drugs in China
    Discussant Ricky Bluthenthal  
10:55-11:10   Break
11:10-12:25   Breakout #2:  
  A Impact of the economic recession on the drug phenomena
    Chair Victoria Greenfield  
      Jenny Chalmers Riding out the global financial crisis? The implications of recession for drug use and harms
      Jeremy Arkes Recessions and the participation of teenagers in the selling and use of illicit drugs
      Cláudia Costa Storti Unemployment and drug treatment
    Discussant Nancy Nicosia  
  B Examining the distribution of drugs
    Chair Kevin Sabet  
      Martin Bouchard Illegal drug supply chains as social networks
      Riccardo Leoncini Counteracting cocaine production: An analysis based on a novel dataset
      Kim Møller An analysis of costs and profits in two Copenhagen cannabis markets
    Discussant Letizia Paoli  
12:30-1:30   Buffet luncheon in RAND courtyard
1:30-2:15 A Plenary #2: Dr. Zunyou Wu, Director National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention
2:15-2:35   Break
2:35-3:50   Breakout #3:
  A Balancing public health, enforcement and harm reduction
    Chair Alex Stevens  
      Nicola Singleton Harm reduction, community engagement and partnership working—perspectives of enforcement personnel in the UK
      Nicolas Fortané Between public health and law enforcement, which mode of regulation for drug policies?
      Susanne MacGregor The framing of drug problems and policy responses: The relative autonomy of local action as illustrated in one English town
    Discussant Harold Pollack  
  B National policy panel II
    Chair Keith Humphreys  
      Jean-Michel Costes Ten years of change on the issue of drugs in France: Public policy, public opinion and media
      Rick Rawson Treatment of opiate addiction in the Egyptian prisons: Promise and challenges
      Asmin Fransiska The future picture of Indonesian drug policy
    Discussant Franz Trautman  
  C Supply-oriented drug control policy transformation
    Chair Paul De Grauwe  
      Letizia Paoli The harms of cocaine trafficking and other criminal activities: Testing a new framework for assessment
      Victoria Greenfield If supply-oriented policy is broken, can "harm reduction" help fix it?
      Andries Zoutendijk Assessing the harms of cocaine trafficking and other organized criminal activities
    Discussant Cláudia Costa Storti  
3:50-4:00   Break
4:00-5:45   Breakout #4:
  A Controlling synthetic drugs: The value of precursor chemical regulations
    Chair Rick Rawson  
      Ross Harvey What's old is new again: A case study of precursor chemical regulation in Queensland
      Wendy Gong Understanding the dynamics of Australian methamphetamine markets: Making better use of price data
      Duane McBride Community collaboration, the development of state methamphetamine precursor policies, and changes in state small toxic lab methamphetamine production
      Nancy Nicosia Are supply-side drug control efforts effective?
    Discussant Rick Rawson  
  B Harms from drug use and policies associated with reducing these harms
    Chair Pia Rosenquist  
      Abbas Motevalian Random drug tests among public vehicle drivers in I.R. Iran
      Stephen Talpins New strategies to curb drugged driving
      Alison Ritter Modelling the allocation of hepatitis C treatment among injecting drug users and its relationship to methadone maintenance treatment
    Discussant Mark Kleiman  
  C The role of national anti-drug media campaigns
    Chair Lawrence Scheier  
      Lawrence Scheier A person-centered approach to examining media campaign effects
      Jason Siegel Translating basic persuasion research to the field: Mass media and drug prevention
      Michael Slater Early adolescent exposure to the U.S. ONDCP "Above the Influence" campaign and impact on beliefs about autonomy and marijuana use behavior
      Leslie Snyder Longitudinal analysis of the impact of alcohol advertising on youth uptake of drinking
5:45-6:30 A ISSDP Business Meeting
6:45-8:30   ISSDP Reception at Casa del Mar Hotel

 

Preliminary Agenda for Tuesday, March 16, 2010

Time Room Activity    
7:45-8:30 A Light breakfast
8:30-9:15 A Plenary #3: Dr. Keith Humphreys, Senior Policy Advisor to the Deputy Director, ONDCP
9:15-9:35   Break
9:40-10:55   Breakout #5:
  A Violence and the war on drugs in producer countries
    Chair Daniel Mejía  
      Jo Thori Lind Opium for the masses? Conflict-induced narcotics production in Afghanistan
      Vanda Felbab-Brown Mexico's violence and lessons from Brazil
      Juan Carlos Echeverry Drug trafficking and impunity in the Lucas islands: Evidence for the United States, Mexico and Colombia
    Discussant Daniel Mejía  
  B Research needs for policy making: Insights from international and national institutions
    Chair Beau Kilmer  
      Sandeep Chawla Research to inform policy: Some insights from the United Nations Office on Drugs and Crime
      Maurice Galla Research challenges for future EU drug policy
      Kevin Sabet President Obama's first national drug control strategy: Who, what, why, and how much?
    Discussant Robert DuPont
  C Prevention and other community approaches to drug policy
    Chair Steve Rolles  
      Raul Melo Me & the Others Project—a preventive approach
      Owen Gallupe Hanging out with the opposite sex: Unstructured socializing, peer group gender composition, and delinquency
      Alcina Lo Social integration programs and mediation strategies
    Discussant Rebecca Collins  
10:55-11:10   Break
11:10-12:25   Breakout #6:
  A Key insights from Project Hope and 24/7 Sobriety Program
    Chair Robert DuPont
      Mark Kleiman Lessons learned from Project Hope I
      Angela Hawkins Lessons learned from Project Hope II
      Judge Steven Alm Lessons learned from Project Hope III
      Attorney General Marty Jackley South Dakota's 24/7 Sobriety Program
    Discussant Rob MacCoun  
  B Liberalization and enforcement of drug laws
    Chair Harold Pollack  
      Julieta Lemaitre Consumer right to a "personal dose" and the war on drugs: A study of liberalization of consumption policies in Bogota, Colombia
      Brendan Hughes Drug offenses: Sentencing and other outcomes
      Caitlin Hughes The drug law enforcement performance monitoring impasse: Analysis and prospects for moving forward
    Discussant Peter Reuter  
  C Factors influencing drug use and drug supply
    Chair Cláudia Costa Storti  
      Anne Line Bretteville-Jensen Decriminalization and initiation into cannabis use
      Mireille Jacobson Population cohort size and marijuana initiation
      Daniel Mejía Competing on price or violence
    Discussant Rosalie Pacula, Nancy Reichmann, Gary Zarkin  
12:30-1:45   Buffet luncheon in RAND courtyard
    Poster Session
1:45-2:30 A Plenary #4: Dr. Maria Elena Medina-Mora, General Director, National Institute of Psychiatry, Mexico and Former member of INCD
2:30-2:50   Break
2:50-4:05   Breakout #7:
  A Marijuana policy
    Chair Rosalie Pacula  
      Amanda Geller Pot as pretext: Marijuana, race and the new disorder in New York City street policing
      Robert MacCoun California Assembly Bill 390 and the Tax and Regulate Cannabis Ballot Initiative: What would happen if California legalized marijuana?
      Chris Wilkins Criminal justice outcomes for cannabis use offences in New Zealand, 1991-2008
    Discussant Paul Heaton, Anne Line Bretteville-Jensen  
  B Drug policy and practice
    Chair Martin Bouchard  
      Alex Stevens Telling policy stories: An ethnographic study of the use of evidence in policy-making in the UK
      Jelica Grbic Factors influencing medical cannabis policy development in the U.S. and their implications
      Freya Vander Laenen Towards community collaboration in drug policy: Best practices
    Discussant Martin Iguchi  
  C Economic benefits and costs of prevention, treatment and welfare reform
    Chair Mireille Jacobson  
      Bohdan Nosyk An empirical specification of the rational addiction model for illicit drug use
      Gary Zarkin Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: Results from a lifetime simulation model
      Hope Corman Effects of welfare reform on illicit drug use of adult women
    Discussant Titus Galama, Susan Paddock, Jeremy Arkes  
4:05-4:20   Break
4:20-6:00   Breakout #8:
  A Roundtable on UNODC panel on improving indicators of drug use, drug problems, and drug markets
    Chair Angela Me  
      Beau Kilmer Drug enforcement and crime indicators
      Alison Ritter Policing indicators and policy indicators
      Margriet van Laar Use and epidemiological measures
      Tomas Zabransky Treatment and AIDS related issues
  B Crime and treatment
    Chair Alex Stevens  
      Harold Pollack If drug treatment works so well, why are so many drug users in prison?
      Ralph Fretz Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders
      Suzette Glasner-Edwards Evidence-Based practices in addiction treatment
    Discussant Christine Grella  
  C Drug markets and the national accounting system
    Chair Kevin Sabet  
      Christopher Doran Including illicit drugs in the national accounts: evidence from Australia
      Roberto Ricci Illicit drug industry in the National Accounts: Some extension of the supply and demand side approaches
      Jiri Vopravil Estimation of drug trade, its inclusion into national accounts system and potential impact on GDP
    Discussant Victoria Greenfield  

 

read more Return to complete conference details